Your browser doesn't support javascript.
loading
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.
Rappold, Phillip M; Vuong, Lynda; Leibold, Josef; Chakiryan, Nicholas H; Curry, Michael; Kuo, Fengshen; Sabio, Erich; Jiang, Hui; Nixon, Briana G; Liu, Ming; Berglund, Anders E; Silagy, Andrew W; Mascareno, Eduardo A; Golkaram, Mahdi; Marker, Mahtab; Reising, Albert; Savchenko, Alexander; Millholland, John; Chen, Ying-Bei; Russo, Paul; Coleman, Jonathan; Reznik, Ed; Manley, Brandon J; Ostrovnaya, Irina; Makarov, Vladimir; DiNatale, Renzo G; Blum, Kyle A; Ma, Xiaoxiao; Chowell, Diego; Li, Ming O; Solit, David B; Lowe, Scott W; Chan, Timothy A; Motzer, Robert J; Voss, Martin H; Hakimi, A Ari.
Afiliação
  • Rappold PM; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Vuong L; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Leibold J; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chakiryan NH; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Curry M; Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tuebingen, Tuebingen, Germany.
  • Kuo F; DFG Cluster of Excellence 2180 Image-Guided and Functional Instructed Tumor Therapy (iFIT), University of Tuebingen, Tuebingen, Germany.
  • Sabio E; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Jiang H; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nixon BG; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Liu M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Berglund AE; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Silagy AW; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Mascareno EA; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Golkaram M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Marker M; Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Reising A; Legend Biotech USA Inc., Upper Saddle River, New Jersey.
  • Savchenko A; Department of Biostatistics and Bioinformatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Millholland J; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chen YB; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Russo P; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Coleman J; Illumina, Inc., San Diego, California.
  • Reznik E; Novartis Oncology, New Hanover, New Jersey.
  • Manley BJ; Novartis Oncology, New Hanover, New Jersey.
  • Ostrovnaya I; Novartis Oncology, New Hanover, New Jersey.
  • Makarov V; Novartis Oncology, New Hanover, New Jersey.
  • DiNatale RG; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Blum KA; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ma X; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chowell D; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Li MO; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Solit DB; Integrated Mathematical Oncology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Lowe SW; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chan TA; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio.
  • Motzer RJ; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Voss MH; Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hakimi AA; Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio.
Cancer Discov ; 12(10): 2308-2329, 2022 10 05.
Article em En | MEDLINE | ID: mdl-35758895
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Idioma: En Ano de publicação: 2022 Tipo de documento: Article